Novartis cancer drug gets approval in Europe
European regulators have approved Glivec, a revolutionary cancer treatment developed by Novartis of Switzerland. Approval of the drug, which some analysts say could have sales of $1bn a year, is
European regulators have approved Glivec, a revolutionary cancer treatment developed by Novartis of Switzerland. Approval of the drug, which some analysts say could have sales of $1bn a year, is